David Meerman Scott
Marketing & Sales Strategist | Inventor of Newsjacking | Bestselling Author of The New Rules of Marketing & PR and Fanocracy | Real-Time Business Advisor
World's Foremost Authority on Human Longevity | Professor of Genetics, Harvard Medical School | Co-Founder, Life Biosciences | Bestselling Author of 'Lifespan'
What if aging itself could be treated, slowed, or reversed? Few scientists have done more to make that question credible than David Sinclair. Professor of Genetics at Harvard Medical School and co-founder of Life Biosciences, Sinclair has reframed aging as a treatable condition and brought the science of longevity from the lab to the executive stage. Audiences gain a clear view of the breakthroughs reshaping health, healthcare, and human potential.
Want to book David Sinclair as a speaker for your event? Please provide the info below and we’ll get in touch within 24h:
Longevity speaker David Sinclair is widely regarded as one of the world’s foremost authorities on the biology of aging and one of the most influential scientific voices arguing that aging can be slowed, treated, and even reversed. He is Professor of Genetics at Harvard Medical School, co-director of the Paul F. Glenn Center for Biology of Aging Research, and the author of the international bestseller Lifespan: Why We Age and Why We Don’t Have To.
Longevity speaker David Sinclair has spent more than two decades at the frontier of aging research. His lab has published over 200 scientific papers and produced more than 50 patents, with his work appearing in Nature, Science, and Cell. He is the architect of the Information Theory of Aging, which proposes that aging is driven by a loss of epigenetic information rather than irreversible damage, and that lost information can be restored, opening a path toward biological rejuvenation.
Sinclair has translated his science into companies that are reshaping the longevity industry. He co-founded Sirtris Pharmaceuticals (acquired by GSK), MetroBiotech, and Life Biosciences, which is now developing partial epigenetic reprogramming gene therapies that have received FDA clearance to enter human clinical trials. His Lifespan podcast brings his research to a global audience, and Time magazine has named him to its 100 Most Influential People in the World and Top 50 People in Healthcare lists.
Sinclair’s central scientific contribution is the idea that aging behaves like information loss in a system, similar to scratches on a CD that disrupt the music underneath. His lab has demonstrated in animal models that partial cellular reprogramming can restore vision, repair tissues, and reverse markers of biological age. These findings are now moving into human trials through Life Biosciences and are being tested against the Information Theory of Aging at clinical scale.
As a speaker, David Sinclair brings senior audiences inside the most important scientific story of our generation: the shift of aging from an inevitability to a treatable condition. He addresses what the next wave of longevity science means for healthcare systems, life sciences investment, insurance, talent strategy, and personal health, translating complex biology into clear, decision-ready insights for executives, investors, and policymakers.
Sinclair takes audiences inside the breakthroughs from his Harvard lab and the wider longevity field, showing how partial epigenetic reprogramming, sirtuin activation, and NAD+ pathways are being used to restore youthful cell function. He explains, in clear language, why these findings have moved aging research from speculative theory to human clinical trials, and what it would mean for medicine if biological age could be measurably reversed.
Most of medicine treats diseases one at a time. Sinclair argues that the single most powerful intervention available to us is to treat aging itself, the upstream cause of cancer, Alzheimer's, cardiovascular disease, and most chronic illness. In this keynote, he lays out what this shift means for hospitals, insurers, pharma, and governments, and how leaders should prepare for a world in which extending healthspan, not just lifespan, becomes the central goal of healthcare.
Sinclair's central scientific thesis is that aging is not damage but the loss of biological information, and that lost information can be recovered. Drawing on his own research and findings from labs worldwide, he walks audiences through the science behind the theory, the experiments that have validated it in animal models, and the human trials now testing whether the same principles apply to people. A talk for audiences that want to understand the actual mechanism behind longevity, not just the promise.
Longevity is no longer a niche science topic. It is a fast-emerging economic sector that touches biotech, consumer health, finance, insurance, real estate, and workforce planning. Sinclair offers a grounded view of where the longevity industry is going, which therapies and platforms are likely to matter, and how executives can think about long-term strategy when human healthspan itself becomes addressable.
| Basic Data Protection Information | |
|---|---|
| Data controller | AURUM SPEAKERS BUREAU S.L. |
| Address | Parc Audiovisual de Catalunya 1, Oficina S11, 08225 Terrassa, Spain |
| Purposes | We will use your data to respond to your requests and deliver our services to you. |
| Marketing | We will only send you marketing correspondence if you have given your prior consent, which you can do by ticking the box for that purpose. |
| Lawful basis | We will only process your data if you have given your prior consent, which you can do by ticking the box for that purpose. |
| Recipients | Generally, only our members of staff who have been duly authorised may access the data that you have provided. |
| Your Rights | You have the right to know what information we hold about you, to rectify it and to erase it, as explained in the additional information available on our website. |
| Additional Information | For more information, please see “PRIVACY POLICY” on our website. |